Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 20/20 | 0.88 |
| ▸ | CCKAR | P32238 | 15/20 | 0.88 |
| ▸ | AMY2A | P04746 | 5/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31274803 | 0.92 | CCKBR (0.83) | CCKBRCCKARAMY2A | |
| SCHEMBL31060625 | 0.91 | CCKBR (0.85) | CCKBRCCKAR | |
| SCHEMBL11568088 | 0.88 | CCKBR (0.80) | CCKBRCCKAR | |
| SCHEMBL3255623 | 0.87 | CCKAR (0.73) | CCKBRCCKAR | |
| SCHEMBL29440092 | 0.85 | CCKAR (0.69) | CCKBRCCKAR | |
| SCHEMBL194796 | 0.84 | CCKBR (0.65) | CCKBRCCKARAMY2A | |
| SCHEMBL11568709 | 0.84 | CCKBR (0.78) | CCKBRCCKAR | |
| Sincalide SCHEMBL23777271 | 0.84 | CCKBR (1.00) | CCKBRCCKAR | |
| Sincalide SCHEMBL29408679 | 0.84 | CCKBR (1.00) | CCKBRCCKAR | |
| Sincalide SCHEMBL1425223 | 0.84 | CCKBR (1.00) | CCKBRCCKAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4057514-B1 | ANALOGUE-DIGITAL CONVERSION DEVICE WITH HIGH SIGNAL/NOISE RATIO | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2026-04-29 | — | — | EP | disclosed |
| CN-119830979-A | Model data processing method, device, computer equipment and storage medium | 鹏城实验室 | 2025-04-15 | — | — | CN | disclosed |
| WO-2023160800-A1 | BIOSIGNATURES FOR FATIGUE SYNDROMES | Laboratorium M. Nuytinck (BE) | 2023-08-31 | — | — | WO | disclosed |
| WO-2023072871-A1 | COMBINED USE OF IMMUNOMODULATORY SUBSTANCES AND PERIPHERAL BLOOD MONONUCLEAR CELLS IN TREATING AND/OR PREVENTING AN INFLAMMATORY DISEASE, IMMUNOLOGICAL DISEASE AND/OR AUTOIMMUNOLOGICAL DISEASE | ELLENNBE GMBH (DE) | 2023-05-04 | — | — | WO | disclosed |
| EP-3376246-B1 | ACCELERATED GENERATION OF A SERIES OF MAGNETIC RESONANCE IMAGES WITH SIMULTANEOUS MAGNETIC RESONANCE MULTI-LAYER IMAGING | SIEMENS HEALTHCARE GMBH (DE) | 2023-04-26 | — | — | EP | disclosed |
| EP-4103179-A1 | COMBINATION THERAPY FOR TREATING AMYOTROPHIC LATERAL USING PRIDOPIDINE AND ANOTHER ACTIVE AGENT | Prilenia Neurotherapeutics Ltd. (IL) | 2022-12-21 | — | — | EP | disclosed |
| EP-4055151-A1 | MODIFIED ADENO-ASSOCIATED VIRUS VECTORS AND DELIVERY THEREOF INTO THE CENTRAL NERVOUS SYSTEM | Coave Therapeutics (FR) | 2022-09-14 | — | — | EP | disclosed |
| EP-4057514-A2 | ANALOGUE-DIGITAL CONVERSION DEVICE WITH HIGH SIGNAL/NOISE RATIO | Commissariat à l'énergie atomique et aux énergies alternatives (FR) | 2022-09-14 | — | — | EP | disclosed |